Published in AIDS on May 12, 2006
Wealth and sexual behaviour among men in Cameroon. BMC Int Health Hum Rights (2006) 1.05
Quality of life in HIV clinical trials: why sexual health must not be ignored. PLoS Clin Trials (2007) 0.76
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis (1999) 4.18
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67
Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 2.70
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
HIV testing in developing countries. Lancet (1997) 2.19
Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis (1999) 2.06
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.86
A new lethal syndrome with cloudy corneae, diaphragmatic defects and distal limb deformities. Hum Genet (1979) 1.79
Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health (1998) 1.75
Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis (1999) 1.73
Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda. Int J STD AIDS (2009) 1.59
Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health (1998) 1.44
Ebola hemorrhagic fever and pregnancy. J Infect Dis (1999) 1.41
Euthanasia: from the perspective of HIV infected persons in Europe. HIV Med (2001) 1.40
Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 1.39
Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS (1992) 1.39
Primary care involvement in human immune deficiency virus infection-a pan-European view. The Eurosupport Study Group. Fam Pract (2000) 1.37
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS (2001) 1.35
Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda. Int J Tuberc Lung Dis (2011) 1.35
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro Surveill (2015) 1.28
Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa. Lancet (1987) 1.27
Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care (2007) 1.25
Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care (2004) 1.19
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study. Antivir Ther (2002) 1.19
Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need? Int J STD AIDS (2009) 1.18
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS (2000) 1.18
T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol (2000) 1.17
Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol (1987) 1.17
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial. Int J STD AIDS (2011) 1.10
Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS (1999) 1.08
Sexual dysfunction with protease inhibitors. Lancet (1999) 1.07
Families affected by HIV: parents' and children's characteristics and disclosure to the children. AIDS Care (2004) 1.06
Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrob Agents Chemother (1997) 1.06
Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol (1999) 1.05
Treatment and prevention of multidrug-resistant tuberculosis. Drugs (1999) 1.05
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett (1998) 1.04
Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994-1995. Acta Trop (2001) 1.04
Evaluation of the WHO clinical case definition for AIDS in rural Zaire. AIDS (1988) 1.04
Uptake of provider-initiated counselling and testing among tuberculosis suspects, Ethiopia. Int J Tuberc Lung Dis (2010) 1.01
Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis (2011) 1.01
Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann Soc Belg Med Trop (1995) 1.00
Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda. Int J STD AIDS (2010) 1.00
Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis (2010) 1.00
Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg (2006) 0.99
The immune reconstitution inflammatory syndrome related to HIV co-infections: a review. Eur J Clin Microbiol Infect Dis (2011) 0.99
Breastfeeding and transmission of HIV. Lancet (1989) 0.95
Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC) Clin Exp Immunol (1998) 0.95
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol (1997) 0.94
Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency. Int J STD AIDS (2013) 0.93
Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis (2012) 0.92
Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. Int J Tuberc Lung Dis (2013) 0.92
Comparison of sensitivities and specificities of latex agglutination and an enzyme-linked immunosorbent assay for detection of antibodies to the human immunodeficiency virus in African sera. J Clin Microbiol (1988) 0.92
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
Adult Still's disease caused by Yersinia enterocolitica infection. Arch Intern Med (1984) 0.92
A frontal mucocele caused by an immune reconstitution inflammatory syndrome in a patient with HIV infection. Rhinology (2008) 0.91
Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. Clin Exp Immunol (1990) 0.90
Surveillance case definition for AIDS in resource-poor countries. Lancet (1993) 0.89
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin Belg (2007) 0.89
Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment. Infection (2003) 0.89
Birds of a feather: homophily and sexual network structure in sub-Saharan Africa. Int J STD AIDS (2013) 0.88
AIDS: an old disease from Africa? Br Med J (Clin Res Ed) (1984) 0.88
Diagnosis of amoebic infection of the liver: report of 36 cases. Ann Soc Belg Med Trop (1995) 0.88
[Validity of an ELISA test for CD4+ T lymphocyte count and validity of total lymphocyte count in the assessment of immunodeficiency status in HIV infection]. Ann Soc Belg Med Trop (1994) 0.88
Clinical manifestations and the natural history of HIV infection in adults. West J Med (1987) 0.88
Deafness caused by didanosine. Eur J Clin Microbiol Infect Dis (1998) 0.87
Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS (2010) 0.87
[Prevalence and incidence of HIV-1 infection among employees of a large textile business and their wives in Kinshasa, 1991-1996]. Rev Epidemiol Sante Publique (2001) 0.87
The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment. Int J STD AIDS (2004) 0.87
Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses (1998) 0.86
The tetraphocomelia-cleft palate syndrome in identical twins. Hum Genet (1980) 0.85
Rheumatological complications associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis (2002) 0.84
Risk factors for and types of oesophageal cancer. Lancet (2004) 0.84
HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training. Lancet (2008) 0.84
Direct costs of health care for HIV/AIDS patients in Belgium. AIDS Care (2001) 0.83
HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses (1998) 0.83
A case of multiple amoebic liver abscesses: clinical improvement after percutaneous aspiration. Acta Clin Belg (2005) 0.83
Development of multiple abscesses in an HIV/TB co-infected patient after initiation of antituberculous and highly active antiretroviral therapy. Acta Clin Belg (2002) 0.83
Mirror, mirror on the wall: the face of HIV + women in Europe today. AIDS Care (2010) 0.83
Selective ambulatory management of imported falciparum malaria: a 5-year prospective study. Eur J Clin Microbiol Infect Dis (2007) 0.83
8p trisomy in a malformed foetus. Ann Genet (1982) 0.82
Development of hyperreactive malarious splenomegaly in an 8 year-old Caucasian boy, 18 months after residence in Africa. Ann Soc Belg Med Trop (1994) 0.82
Management of co-infection with HIV and TB. BMJ (2002) 0.82
Prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis and Micrococcus species successfully treated with rifampicin combined with other antibiotics. J Infect (1985) 0.82
Editorial: giving antiretrovirals in the peripartum period to prevent mother-to-child HIV transmission in low-income countries: only a short-term stopgap measure. Trop Med Int Health (2003) 0.81
Pulmonary haematoma caused by oral anticoagulant therapy. Report of a case. Acta Radiol Diagn (Stockh) (1983) 0.81
Inhaled corticosteroids in persons with HIV infection: not that harmless. Acta Clin Belg (2012) 0.81
Sarcoidosis after testicular carcinoma treatment. AJR Am J Roentgenol (1983) 0.81
Evaluation of two staging systems for HIV infection for use in developing countries. AIDS (1993) 0.80
Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group. J Infect Dis (1997) 0.80
Does European or non-European origin influence health care and prognosis for HIV patients in Europe? The EuroSIDA Study Group. HIV Med (1999) 0.80
The HIV epidemic in Kinshasa, Democratic Republic of Congo. Int J STD AIDS (2001) 0.80
Receiving a positive HIV test result: the experience of patients in Europe. HIV Med (2001) 0.80
A cluster of airport malaria in Belgium in 1995. Acta Clin Belg (1998) 0.80